High doses of radiation also in peripheral procedures

Original title: Patient radiation exposure during percutaneous endovascular revascularization of the lower extremity. Reference: Einat Segal et al. Journal of Vascular Surgery. Article in press.

Percutaneous endovascular revascularization is emerging as the first line treatment for peripheral artery disease for both intermittent claudication and chronic critical limb ischemia. Radiation doses for these interventions, usually prolonged, have not been well documented.

This retrospective study evaluated all lower extremity angioplasty procedures between 2006 and 2011 in a single center. Fluoroscopy time and dose area product (DAP) were registered. 382 procedures in 313 patients receiving lower extremity revascularization were included; a significantly higher DAP was observed in the primitive or the external iliac arteries compared to those performed in femoropopliteal (179.6 vs 63.2 Gy/cm2; p

The contraleteral access resulted in a in a higher DAP than the antegrade access (112.2 vs 42.6 Gy/cm2; p < 0.0001). In a multivariable analysis, the anatomical location of lesions presented the strongest association with radiation dose (p

Conclusion:

Revascularization procedures on lower extremities involve substantial radiation doses that can be compared, on average, with abdomen and pelvis CT scans. Pelvis procedures involve higher doses than those performed in femoropopliteal or infrapatellar territories.

 Editorial Comment:

Radiation doses should be taken into account especially in recanalization procedures of iliac arteries. For femoral or intrapatellar procedures, the antegrade access should be preferred whenever possible. Both the technical difficulty of puncture and the greater chance of complications should be counterbalanced with greater support, a stronger drive and now also lower radiation doses.

SOLACI.ORG

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....